Management of open wounds in dogs using a bioresorbable polymeric wound matrix: 14 cases (2019-2021)

• Published in: Topics in companion animal medicine 2023-09, Vol.56-57, p.100825-100825, Article 100825
• Main Authors: Carrillo, A.J., Mancuso, M.L., Maxwell, E.A.
• Format: Article
• Language: English
• Subjects: Biomaterials; Small animal; Soft tissue surgery; Wound management
• ISSN: 1938-9736; 1946-9837
• DOI: 10.1016/j.tcam.2023.100825

•The wound matrix may be utilized in acute and chronic wounds.•Use of the wound matrix aided in facilitation of healing in all wounds.•No adverse events were directly attributed to the use of the wound matrix. The objective of this retrospective case series is to evaluate clinical outcomes associated with the use of a bioresorbable polymeric wound matrix (MicroLyte Vet; Imbed Biosciences) for the management of soft tissue wounds of various etiologies in dogs. Medical records were reviewed between August 2019 and November 2021 for signalment, wound etiology, location, size, initial wound management, antibiotic therapy, time to initial application, number of applications, time between applications, secondary dressing used, time to wound closure, complications, and clinical outcomes. Time to initial application ranged from 1 to 61 days (median, 7.5). The number of applications ranged from 1 to 15 (median, 4.5). Time between applications ranged from 1 to 8 days (median, 3.7). Additional surgical interventions were implemented in 3 dogs. Wound closure by second intention healing (n=14) ranged from 2 to 12 weeks (median, 5). There were no adverse events attributed to the use of bioresorbable polymeric wound matrix. Complete wound healing occurred with use of the bioresorbable polymeric wound matrix in all dogs.